Progress on treatment with antibody-laden blood cuts risk of severe COVID
A clinical trial in older adults with COVID-19 shows that an early dose of blood plasma from recovered people helps to prevent the progression to severe disease.
Severe COVID-19 developed in 16% of the 80 study participants who received plasma and 31% of the 80 participants in the placebo group. The team found that donor plasma containing higher concentrations of antibodies against SARS-CoV-2 was associated with a greater reduction in the risk of developing severe disease — providing evidence that the antibodies themselves are responsible for the therapeutic effect.
In hospitalized patients with Covid-19, the infusion of convalescent plasma against SARS-CoV-2 late in the course of illness has not shown clear benefits and, consequently, the most appropriate antibody concentrations for effective treatment are unclear. We evaluated whether convalescent plasma with high SARS-CoV-2 antibody titers, administered within 72 hours after the onset of mild symptoms, would be efficacious in preventing progression to severe disease in older adult patients with Covid-19. The New England Journal Of Medicine</a
Covid 19 accelerate technology applications in healthcare system – Tele medicine else remote Patient Monitoring (RPM).
Tele health monitoring speed up its innovation to new level as Covid 19 arrivals. Both Doctors and Patients who used the tele med Apps know the benefits of it. There are three main types of telemedicine:
2. remote monitoring
3. real-time interactive services.
Each of these has a beneficial role to play in overall health care and, when utilized properly, can offer substantial benefits for both healthcare workers and patients. Here are the few highlights from Harvard Business review article by Dr. Marc Harrison MD:
• Telehealth has expanded access to better and faster care.
• Digital care is safer during the pandemic.
• Telehealth’s clinical quality is excellent.
• Digital tools support the direction health care is headed.
• Many doctors tried telehealth and liked it.
• Security, privacy, and fixing technical flaws are ongoing priorities.
• Technology should be kept simple but should be comprehensive. Harvard Business Review
WHY MASK USE IS SO IMPORTANT FOR PREVENT SPREAD OF COVID-19?US Centers for Disease Control and Prevention, CDC emphasizes that wearing a mask is so important since the most covid-19 infections are spread by people without showing symptoms. Further elaborating on science. CDC Website concludes “Experimental and epidemiological data support community masking to reduce the spread of SARS-CoV-2. The prevention benefit of masking is derived from the combination of source control and personal protection for the mask wearer”
India’s new paper Covid-19 test could be a ‘game changer’
A team of scientists in India has developed an inexpensive paper-based test for coronavirus that could give fast results similar to a pregnancy test.
Climate change and COVID-19: Does global warming fuel pandemics?
“We have entered a pandemic era,” said a recent study in the journal Cell. Written by Dr. Anthony Fauci and medical historian Dr. David Morens, both of the National Institute of Allergy and Infectious Diseases, the study paints a picture of a future where pandemics become more numerous. Click Here
We Can Solve the Coronavirus-Test Mess Now—If We Want To
To get out of this pandemic, we need fast, easy coronavirus testing that’s accessible to everyone. From the way people often talk, you might think we need a technological breakthrough to achieve this. In fact, we don’t have a technological problem; we’ve got an implementation problem. We could have the testing capacity we need within weeks. The reason we don’t is not simply that our national leadership is unfit but also that our health-care system is dysfunctional.Click Here
PFIZER AND BIONTECH ANNOUNCE VACCINE CANDIDATE AGAINST COVID-19 IS A SUCCESS
Pfizer says application of science is the key to the development of the vaccine with prudently following the standard for quality, safety and value in the breakthrough.
“At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies” Click Here
World Health Organization says, REMDESIVIR does not help Covid-19 patient
In a study it described as both conclusive and disappointing, the World Health Organization said the antiviral drug remdesivir has “little or no effect on mortality” for patients hospitalized with coronavirus, and it doesn’t seem to help patients recover any faster, either. Click Here
People with blood type O may have lower risk of Covid-19 infection and severe illness, two new studies suggest
People with blood type O may be less vulnerable to Covid-19 and have a reduced likelihood of getting severely ill, according to two studies published Wednesday. Experts say more research is needed.